EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice

Seulgi Shin, Hyejung Jo, Tomoyo Agura, Seoyoun Jeong, Hyovin Ahn, Yejin Kim, Jae Seung Kang iD

Journal of Materials Chemistry B · 2024

DOI: 10.1039/d4tb00631c ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2024. Verfasst von Seulgi Shin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Vitamin C and Antioxidant Immunology, Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul 0308…. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Nanoparticles, Silicon. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Octadecylated pSiNPs efficiently deliver TMZ to the brain, enhancing its accumulation and anticancer effects, resulting in extended survival in glioma-bearing mice. It highlights its potential as a promising drug delivery platform for the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaNanoparticlesSiliconBrain NeoplasmsSurface PropertiesAntineoplastic Agents, AlkylatingAnimalsMicePorosityHumansParticle SizeDrug Delivery SystemsDrug CarriersMice, Nude

Substanzen

TemozolomideSiliconAntineoplastic Agents, AlkylatingDrug Carriers

Autor:innen und Institutionen

  • Laboratory of Vitamin C and Antioxidant Immunology, Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea. bbambaya921@snu.ac.kr.
  • Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Republic of Korea.
  • Department of Research and Development, N therapeutics Co., Ltd, Seoul 08813, Republic of Korea.
  • Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.

ORCID-Profile: Jae Seung Kang

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Shin, S., Jo, H., Agura, T., Jeong, S., Ahn, H., Kim, Y., & Kang, J. S. (2024). Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice. Journal of Materials Chemistry B. https://doi.org/10.1039/d4tb00631c

Vancouver

Shin S, Jo H, Agura T, Jeong S, Ahn H, Kim Y, et al. Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice. Journal of Materials Chemistry B. 2024. doi:10.1039/d4tb00631c

BibTeX
@article{Shin2024,
  author = {Shin, Seulgi and Jo, Hyejung and Agura, Tomoyo and Jeong, Seoyoun and Ahn, Hyovin and Kim, Yejin and Kang, Jae Seung},
  title = {Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice},
  journal = {Journal of Materials Chemistry B},
  year = {2024},
  doi = {10.1039/d4tb00631c}
}
Kostenlos starten →